ReCap Total Hip Resurfacing Prospective Data Collection

This study has been terminated.

First Received on September 23, 2008. Last Updated on May 4, 2012 History of Changes

Sponsor:	Biomet, Inc.
Collaborator:	Biomet U.K. Ltd.
Information provided by (Responsible Party):	Biomet, Inc.
ClinicalTrials.gov Identifier:	NCT00758472

Purpose

Prospective data collection on survivorship of ReCap Total Hip Resurfacing

Condition	Intervention
Arthritis	Device: ReCap Total Hip Resurfacing

Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	ReCap Total Hip Resurfacing Prospective Data Collection

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:

Enrollment:	82
Study Start Date:	March 2005
Study Completion Date:	March 2010
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
Hip Resurfacing	Device: ReCap Total Hip Resurfacing ReCap Total Hip Resurfacing Other Name: RECAP

Detailed Description:

Detailed protocol not available

Eligibility

Study Population

Patients suitable for Total Hip Resurfacing

Criteria

Inclusion Criteria:

Exclusion criteria:

- less than 18 years of age

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00758472

Locations

United Kingdom
Southmead Hospital
Bristol, United Kingdom
Robert Jones & Agnes Hunt Orthopaedic & District Hospital NHS Trust
Oswestry, United Kingdom

Sponsors and Collaborators

Biomet, Inc.

Biomet U.K. Ltd.

Investigators

Principal Investigator:

Evert Smith, MD

North Bristol NHS Trust

More Information

No publications provided

Responsible Party:	Biomet, Inc.
ClinicalTrials.gov Identifier:	NCT00758472 History of Changes
Other Study ID Numbers:	BMET UK 08
Study First Received:	September 23, 2008
Last Updated:	May 4, 2012
Health Authority:	United Kingdom: Medicines and Healthcare Products Regulatory Agency

Additional relevant MeSH terms:

Arthritis
Joint Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on May 24, 2012